These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 25378633)
1. Light at the end of the tunnel: towards an effective drug therapy for surgery- and radiation-refractory meningioma. Marosi C Neuro Oncol; 2015 Jan; 17(1):7-8. PubMed ID: 25378633 [No Abstract] [Full Text] [Related]
2. Recurrent anaplastic meningioma treated by sunitinib based on results from quantitative proteomics. Yoshikawa A; Nakada M; Ohtsuki S; Hayashi Y; Obuchi W; Sato Y; Ikeda C; Watanabe T; Kawahara Y; Hasegawa T; Sabit H; Kita D; Hayashi Y; Nakanuma Y; Terasaki T; Hamada JI Neuropathol Appl Neurobiol; 2012 Feb; 38(1):105-10. PubMed ID: 21696419 [No Abstract] [Full Text] [Related]
3. Sunitinib for atypical and anaplastic meningioma. Rahman A Lancet Oncol; 2014 Sep; 15(10):e424. PubMed ID: 25328951 [No Abstract] [Full Text] [Related]
4. Targeted drug therapy for meningiomas. Norden AD; Drappatz J; Wen PY Neurosurg Focus; 2007; 23(4):E12. PubMed ID: 17961036 [TBL] [Abstract][Full Text] [Related]
5. Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363. Weller M; Roth P; Sahm F; Burghardt I; Schuknecht B; Rushing EJ; Regli L; Lindemann JP; von Deimling A J Natl Cancer Inst; 2017 Mar; 109(3):1-4. PubMed ID: 28376212 [TBL] [Abstract][Full Text] [Related]
15. Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature. Paix A; Waissi W; Antoni D; Adeduntan R; Noël G Cancer Radiother; 2017 Feb; 21(1):55-59. PubMed ID: 28237610 [TBL] [Abstract][Full Text] [Related]
16. Meningioma of the optic nerve sheath: treatment with hydroxyurea. Paus S; Klockgether T; Urbach H; Schlegel U J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1348-50. PubMed ID: 12933956 [No Abstract] [Full Text] [Related]
17. Doxil-induced regression of pleuro-pulmonary metastases in a patient with malignant meningioma. Travitzky M; Libson E; Nemirovsky I; Hadas I; Gabizon A Anticancer Drugs; 2003 Mar; 14(3):247-50. PubMed ID: 12634620 [TBL] [Abstract][Full Text] [Related]
18. Regression of a presumed meningioma with the antiestrogen agent mepitiostane. Case report. Oura S; Sakurai T; Yoshimura G; Tamaki T; Umemura T; Kokawa Y; Masuo O; Naito Y J Neurosurg; 2000 Jul; 93(1):132-5. PubMed ID: 10883917 [TBL] [Abstract][Full Text] [Related]
19. Treatment of high risk or recurrent meningiomas with hydroxyurea. Rosenthal MA; Ashley DL; Cher L J Clin Neurosci; 2002 Mar; 9(2):156-8. PubMed ID: 11922703 [TBL] [Abstract][Full Text] [Related]
20. Regression of intracranial meningioma following treatment with nivolumab: Case report and review of the literature. Gelerstein E; Berger A; Jonas-Kimchi T; Strauss I; Kanner AA; Blumenthal DT; Gottfried M; Margalit N; Ram Z; Shahar T J Clin Neurosci; 2017 Mar; 37():51-53. PubMed ID: 28089420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]